AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
GSK Gains Limelight With Upgraded 2024 Guidance
August 01, 2024 12:53 AM AEST| By Team Kalkine MediaGSK (,LSE:GSK,) has delivered a strong financial performance for the second quarter of 2024, demonstrating substantial growth across its portfolio. The company achieved total sales of £7.9 billion, marking a 13% increase compared to the previous year...
Genedrive (AIM: GDR) Receives FDA Breakthrough Device Designation for MT-RNR1 ID Kit
July 15, 2024 05:04 PM AEST| By Team Kalkine MediaGenedrive plc (,AIM: GDR,), a leader in point-of-care pharmacogenetic testing, has announced the receipt of Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Genedrive® MT-RNR1 ID Kit. This designation accelerat...
Scancell Holdings (AIM: SCLP) Strikes Exclusive Evaluation Deal with Major Biotech Firm
June 12, 2024 05:45 PM AEST| By Team Kalkine MediaScancell Holdings plc (,AIM: SCLP,), a pioneer in the realm of oncology immunotherapies, has made waves once again with a significant announcement. The company revealed today that a major international biotechnology firm will exclusively evaluate one...
ANGLE plc (AIM: AGL) Announces £8.5 Million Fundraising
June 05, 2024 06:23 PM AEST| By Team Kalkine MediaANGLE plc (,AIM: AGL,), a global leader in liquid biopsy technology, has announced plans for a significant fundraising effort aimed at raising approximately £8.5 million. This initiative, comprising a combination of placing, subscription, and open of...
Prescription for Profit: Investing in LON Healthcare Stocks for Healthy Returns and Market Dominance
June 22, 2023 08:26 PM AEST| By Team Kalkine MediaThe healthcare sector is a vital and ever-growing industry that offers significant investment opportunities. In this article, we will explore the world of,LON healthcare stocks,and the potential they hold for investors seeking healthy returns and mar...
Healthcare stocks to explore amidst education and health sectors strikes
May 15, 2023 05:56 PM AEST| By Manu ShankarHighlights The country was again in crisis as thousands of healthcare and education professionals went on strike, increasing the already prevalent staff and pay crisis. The latest issue was identified following a survey which concluded they could...
Stocks to watch as the UK invests in the fight against deadly diseases
November 15, 2022 01:10 AM AEDT| By Rishika RainaOver the course of 3 years, the UK is channelising funds worth £1 billion towards the Global Fund.
Which FTSE health-related stocks to check out right now?
November 14, 2022 10:10 PM AEDT| By Abhishek SharmaHighlights:,The Rishi Sunak government will face its first acid test as they gear up for the Autumn budget.,The fiscal statement is all set to be released on 17 November.,Brits are awaiting this week's Autumn budget as Rishi Sunak has pledged that he...
AstraZeneca boosts earnings guidance while demand strengthens
November 11, 2022 12:44 AM AEDT| By Rishika RainaAstraZeneca declared its YTD and Q3 2022 results on Thursday.
Key stocks to watch as new clinical trials in UK declines
October 20, 2022 08:15 PM AEDT| By Rishika Raina• The fall in clinical trials poses a severe threat to the country’s status as a clinical research hub.
PM Truss urged to put billions into social care
September 23, 2022 05:29 PM AEST| By Rishika RainaIn her campaign, the PM had pledged to spend £13 billion on social care.
Haleon IPO: GSK gets shareholders' nod; all you should know
July 07, 2022 05:45 PM AEST| By Abhishek SharmaHighlights:,GSK Plc on Wednesday received approval from the shareholders for the demerger of its consumer healthcare arm.,The new entity, called Haleon, will be listed on the London Stock Exchange on 18 July.,In what will be the largest listing on th...
AZN, GSK, HIK: Pharma stocks to consider amid fears of poliovirus spread
June 23, 2022 05:43 PM AEST| By Abhishek SharmaHighlights:,Several closely-related poliovirus samples were found in the North and East London sewage.,The detection indicates there's been some spread in the regions, according to the UK Health and Security Agency.,Fears have gripped the UK after sa...
GSK's spin-off Haleon to be listed on LSE: Should you hold stock?
June 16, 2022 07:50 PM AEST| By Abhishek SharmaPharma giant GSK plc (LON: GSK), which was previously known as GlaxoSmithKline plc, had in February announced that it would demerge its consumer healthcare business into a separate arm called Haleon. The new company is expected to be listed on the .....
Should you go for GlaxoSmithKline (GSK) share after solid Q1 results?
April 28, 2022 05:47 PM AEST| By Team Kalkine MediaHighlights GlaxoSmithKline Plc announced its Q1 2022 results on Wednesday and surpassed expectations with a turnover of £9.8 billion. The growth was led by the strong sales of GSK's COVID-19 drug Xevudy as the company generated £1.3...
AstraZeneca vs GlaxoSmithKline: Pharma stocks to keep an eye on
April 20, 2022 05:42 PM AEST| By Rishika RainaLeading British pharmaceutical company GlaxoSmithKline plc (LON: GSK) has been in the limelight lately after securing triumph for its drug with US regulator Food and Drug Administration (FDA) in relation to the treatment of anaemia in patients suff.....
.jpg)
Is OKYO Pharma (LON: OKYO) going for a Nasdaq listing?
March 08, 2022 11:42 PM AEDT| By Rishika RainaHighlights OKYO Pharma is aiming to get its ADSs listed on Nasdaq and has submitted a registration statement with the US SEC for the same. The exclusive book-running manager for the IPO is the California-based investment banking firm ThinkEquit.....
.jpg)
GlaxoSmithKline (LON: GSK) to start a new business era with Haleon
February 23, 2022 08:28 PM AEDT| By Sreenivas D AjankarHighlights GlaxoSmithKline Plc has come one step closer to the proposed demerger of its consumer healthcare business by announcing the name of the new entity. The proposed demerger will be a milestone in the company’s history which was fi.....
.jpg)
AstraZeneca (AZN) predicts higher sales in 2022: Should you buy now?
February 11, 2022 05:43 PM AEDT| By Rishika RainaHighlights London’s FTSE100 index was in a buoyant mood on 10 February after it saw third day of gains in a row. The total revenues of AstraZeneca increased by 41% to $37,417 million in 2021, and it has raised its 2022 sales forecas.....
.jpg)
GlaxoSmithKline (GSK) shares: Are they worth your attention?
February 10, 2022 09:21 PM AEDT| By Priya BhandariBritish pharmaceutical giant GlaxoSmithKline Plc (LON: GSK) is back in the news after the company reported robust results for the year 2021 before the structured disposal of its consumer healthcare division. The company reported a 9% hike in its ad.....
AI on the Rise: A Look at Top AI Companies and Their Stocks